Life Sciences

California Supreme Court declines to hear Wyeth case

Pharma Compliance Alert, February 18, 2009

A California appeals court decision stays since the state’s Supreme Court declined to review an earlier decision that held Wyeth liable for patient injuries originating from a generic version of its acid-reflux medication Reglan.

Read more about the California Supreme Court's decision not to review the case.

Most Popular